Oscar Health Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Wichtige Informationen
71.5%
Wachstumsrate der Gewinne
71.4%
EPS-Wachstumsrate
Insurance Gewinnwachstum | 9.0% |
Wachstumsrate der Einnahmen | 21.8% |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 11 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 11Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Feb 10Recent updates
Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 11Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump
May 03Oscar Health: Strong Industry Catalyst With Margin Expansion Potential
Apr 13This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts
Feb 12Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Feb 10Oscar Health: Flexible Business Model Is Paying Off
Jan 30Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce
Jan 19Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward
Nov 21Oscar Health: Q3 Earnings Suggest Growth Can Continue Into 2024
Nov 15Oscar Health: Decreasing Memberships Is Worrying
Sep 22Oscar Health Shares Quadrupled, But They Are Still Cheap
Jul 03Oscar Health: High Growth And Improving Profitability Make It A Buy
Jun 15Oscar Health Insurance GAAP EPS of -$1.05 beats by $0.03, revenue of $995M misses by $415M
Feb 09Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable
Jan 18Oscar Health Is Back On Track
Nov 11Oscar Health: Improving Risk/Reward Profile To Watch
Oct 03Florida health insurer terminating agreement with Oscar Health
Aug 30Oscar Health Grows Revenue But Needs Progress To Profitability
Jul 08Oscar Health: The Future Of Healthcare At A Reasonable Valuation
Mar 13Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 13,279 | 428 | 758 | 700 | 4 |
12/31/2025 | 11,269 | 224 | 465 | 443 | 4 |
12/31/2024 | 8,992 | 26 | 770 | 162 | 4 |
3/31/2024 | 6,534 | -54 | -77 | -53 | N/A |
12/31/2023 | 5,861 | -271 | -298 | -272 | N/A |
9/30/2023 | 5,441 | -347 | -444 | -418 | N/A |
6/30/2023 | 4,983 | -474 | 154 | 183 | N/A |
3/31/2023 | 4,482 | -571 | 202 | 232 | N/A |
12/31/2022 | 3,989 | -606 | 351 | 380 | N/A |
9/30/2022 | 3,519 | -579 | 234 | 263 | N/A |
6/30/2022 | 2,983 | -598 | 197 | 223 | N/A |
3/31/2022 | 2,491 | -559 | 38 | 63 | N/A |
12/31/2021 | 1,894 | -573 | -208 | -182 | N/A |
9/30/2021 | 1,439 | -571 | -149 | -127 | N/A |
6/30/2021 | 1,096 | -439 | 224 | 243 | N/A |
3/31/2021 | 682 | -406 | 417 | 434 | N/A |
12/31/2020 | 391 | -414 | 209 | 223 | N/A |
12/31/2019 | 476 | -261 | -191 | -165 | N/A |